Novel Biomarkers for Heart Disease

Novel Biomarkers for Heart Disease

Cardiac biomarkers such as troponins and natiuretic peptides have made a great impact on clinical decision making as well as improving our understanding of molecular mechanisms of different disease conditions. However, the biomarkers that are currently in use do not reflect all the multiple disease...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Andere auteurs: Lichtenauer, Michael (Redacteur)
Formaat: Hoofdstuk
Gepubliceerd in: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
Onderwerpen:
Medicine
diet quality
ceramides
obesity
cardiovascular risk
healthy eating index
carbohydrate antigen-125
heart failure
inflammatory marker
older women
biomarker
cardiometabolic disease
epicardial adipose tissue
epicardial fat
epicardial fat volume
microRNA
thyroid-stimulating hormone
cardiometabolic risks
metabolic syndrome
hypertension
very low-density lipoprotein
STIM1
SOCE
atrial myopathy
atrial fibrillation
ejection fraction
soluble urokinase-type plasminogen activator receptor (suPAR)
growth differentiation factor 15 (GDF-15)
heart-type fatty acid-binding protein (H-FABP)
soluble suppression of tumorigenicity 2 (sST2)
acute myocardial infarction
biomarkers
catestatin
coronary artery disease
heart failure decompensation
left ventricular ejection fraction
troponin
NT-proBNP
NYHA functional class
GDF-15
cardiovascular surgery
operative risk
muscle wasting
sarcopenia
renal dysfunction
chronic kidney disease
aortic disease
aneurysm
miRNA
TGF-β pathway
KLF4
synthetic phenotype
aortic regurgitation
echocardiography
magnetic resonance imaging
vena contracta area
longitudinal strain
T1 mapping
GDF8
myostatin
AMI
ceruloplasmin
H-FABP
heart-type fatty acid-binding protein
FABP3
fatty acid-binding protein 3
HF
cardiac biomarkers
cardiac magnetic resonance imaging
left ventricular systolic function
magnetic resonance spectroscopy
myocardial triglyceride content
cell adhesion molecule
repeated measurements
pregnancy-associated plasma protein-A
cohort studies
cardiovascular diseases
mitochondrial dysfunction
circulating cells
PBMCS
platelets
oxidative stress
reactive oxygen species (ROS)
mitochondrial DNA (mtDNA)
herat failure
liver-type fatty-acid-binding protein
long-term outcomes
cardiac intensive care units
acute kidney injury
myocardial infarction
STEMI
cardiovascular events
cardiovascular death
risk stratification
sST2
Pentraxin-3
sudden cardiac death
ventricular arrhythmia
ventricular tachycardia
chronic heart failure
saliva
salivary biomarkers
CKD
CVD
PPCI
left ventricular adverse remodelling
circulating miRNAs
NAFLD
Framingham risk score
risk prediction
secondary prevention
primary prevention
NAFLD fibrosis score
HFpEF
HFrEF
suPAR
n/a
Online toegang:Get Fullteks
DOAB: description of the publication
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

Get Fullteks
DOAB: description of the publication

3rd Floor Main Library

Exemplaargegevens van 3rd Floor Main Library
Plaatsingsnummer: A1234.567
Kopie 1 Beschikbaar

Gelijkaardige items